Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie O'Neal

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
AORN Journal|April 30, 2021
Strategies to Implement a Competency Assessment Verification ProgramJulie O'Neal, Jennifer L Fencl
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2003
An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in miceJay L Grisolano, Julie O'Neal, Jennifer Cain, et al.
Frontiers in Immunology|August 22, 2024
Traversing the bench to bedside journey for iNKT cell therapiesJulie O'Neal, Melissa Mavers, Reyka G Jayasinghe, et al.
Blood|June 24, 2005
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutationsHui Luo, Qing Li, Julie O'Neal, et al.
Breast Cancer Research and Treatment|September 11, 2016
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancerJulie O'Neal, Amy Clem, Lindsey Reynolds, et al.
Blood|January 16, 2007
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosageJennifer A Cain, Zhifu Xiang, Julie O'Neal, et al.
Journal of Cellular Biochemistry|August 23, 2014
Glucose availability and glycolytic metabolism dictate glycosphingolipid levelsMorgan Stathem, Subathra Marimuthu, Julie O'Neal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Development of [<sup>89</sup>Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myelomaAnchal Ghai, Alexander Zheleznyak, Matt Mixdorf, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Journal of Cellular and Molecular Medicine|January 11, 2022
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapyKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
AORN Journal|April 30, 2021
Strategies to Implement a Competency Assessment Verification ProgramJulie O'Neal, Jennifer L Fencl
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2003
An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in miceJay L Grisolano, Julie O'Neal, Jennifer Cain, et al.
Frontiers in Immunology|August 22, 2024
Traversing the bench to bedside journey for iNKT cell therapiesJulie O'Neal, Melissa Mavers, Reyka G Jayasinghe, et al.
Blood|June 24, 2005
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutationsHui Luo, Qing Li, Julie O'Neal, et al.
Breast Cancer Research and Treatment|September 11, 2016
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancerJulie O'Neal, Amy Clem, Lindsey Reynolds, et al.
Blood|January 16, 2007
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosageJennifer A Cain, Zhifu Xiang, Julie O'Neal, et al.
Journal of Cellular Biochemistry|August 23, 2014
Glucose availability and glycolytic metabolism dictate glycosphingolipid levelsMorgan Stathem, Subathra Marimuthu, Julie O'Neal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Development of [<sup>89</sup>Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myelomaAnchal Ghai, Alexander Zheleznyak, Matt Mixdorf, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Journal of Cellular and Molecular Medicine|January 11, 2022
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapyKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
Pageof 3